Tenet Healthcare Co. (NYSE:THC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Tenet Healthcare Co. (NYSE:THCGet Free Report) has earned a consensus rating of “Moderate Buy” from the eighteen analysts that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, fourteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $163.88.

THC has been the topic of a number of research analyst reports. Wells Fargo & Company lowered shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and cut their target price for the company from $205.00 to $150.00 in a research report on Monday, November 25th. KeyCorp cut their target price on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Barclays cut their price target on shares of Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating on the stock in a report on Thursday, February 13th. Truist Financial cut their price target on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $177.00 price target on shares of Tenet Healthcare in a report on Thursday, February 13th.

View Our Latest Research Report on Tenet Healthcare

Insider Buying and Selling at Tenet Healthcare

In other news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the transaction, the director now directly owns 27,378 shares in the company, valued at $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.93% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Tenet Healthcare during the fourth quarter valued at about $8,783,000. Forum Financial Management LP grew its holdings in shares of Tenet Healthcare by 43.5% during the fourth quarter. Forum Financial Management LP now owns 2,469 shares of the company’s stock valued at $312,000 after buying an additional 749 shares during the last quarter. Neo Ivy Capital Management acquired a new position in shares of Tenet Healthcare during the fourth quarter valued at about $2,773,000. Vise Technologies Inc. boosted its holdings in Tenet Healthcare by 28.4% during the fourth quarter. Vise Technologies Inc. now owns 1,613 shares of the company’s stock worth $204,000 after purchasing an additional 357 shares during the last quarter. Finally, MidWestOne Financial Group Inc. boosted its holdings in Tenet Healthcare by 6.7% during the fourth quarter. MidWestOne Financial Group Inc. now owns 11,822 shares of the company’s stock worth $1,492,000 after purchasing an additional 744 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Stock Performance

NYSE THC opened at $122.76 on Monday. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25. The firm has a market capitalization of $11.68 billion, a price-to-earnings ratio of 3.81, a P/E/G ratio of 1.02 and a beta of 2.06. The firm’s 50 day simple moving average is $132.46 and its 200 day simple moving average is $144.75. Tenet Healthcare has a 1 year low of $90.03 and a 1 year high of $171.20.

Tenet Healthcare (NYSE:THCGet Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. As a group, research analysts expect that Tenet Healthcare will post 12.24 earnings per share for the current fiscal year.

About Tenet Healthcare

(Get Free Report

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Recommended Stories

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.